Interleukin-5 Receptor alpha Subunit
"Interleukin-5 Receptor alpha Subunit" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A low affinity interleukin-5 receptor subunit that combines with the CYTOKINE RECEPTOR COMMON BETA SUBUNIT to form a high affinity receptor for INTERLEUKIN-5. Several isoforms of the interleukin-5 receptor alpha subunit exist due to multiple ALTERNATIVE SPLICING.
| Descriptor ID |
D053666
|
| MeSH Number(s) |
D12.776.543.750.705.852.420.380.750
|
| Concept/Terms |
Interleukin-5 Receptor alpha Subunit- Interleukin-5 Receptor alpha Subunit
- Interleukin 5 Receptor alpha Subunit
- Interleukin-5 Receptor alpha Chain
- Interleukin 5 Receptor alpha Chain
- CD125 Antigens
- CD125 Antigen
- Antigen, CD125
- Antigens, CD125
- alpha-Subunit, Receptor, Interleukin-5
- Receptor, Interleukin-5, alpha Subunit
|
Below are MeSH descriptors whose meaning is more general than "Interleukin-5 Receptor alpha Subunit".
Below are MeSH descriptors whose meaning is more specific than "Interleukin-5 Receptor alpha Subunit".
This graph shows the total number of publications written about "Interleukin-5 Receptor alpha Subunit" by people in this website by year, and whether "Interleukin-5 Receptor alpha Subunit" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 3 | 4 |
| 2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Interleukin-5 Receptor alpha Subunit" by people in Profiles.
-
Anti-IL-5 and IL-5Ra: Efficacy and Safety of New Therapeutic Strategies in Severe Uncontrolled Asthma. Biomed Res Int. 2018; 2018:5698212.
-
Benralizumab for the treatment of asthma. Drugs Today (Barc). 2017 Dec; 53(12):633-645.
-
Pharmacokinetic/pharmacodynamic drug evaluation of benralizumab for the treatment of asthma. Expert Opin Drug Metab Toxicol. 2017 Sep; 13(9):1007-1013.
-
Targeting Interleukin-5 or Interleukin-5Ra: Safety Considerations. Drug Saf. 2017 07; 40(7):559-570.
-
Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma. N Engl J Med. 2017 06 22; 376(25):2448-2458.